
Ensuring Coverage of Faster Biomarker Testing in Lung Cancer: Robert Kratzke, MD
Delays in molecular testing for patients with non–small cell lung cancer (NSCLC) can lead to treatment lags that cost lives, warned Robert Kratzke, MD, professor of medicine and head of medical oncology at the University of Minnesota. In an interview with …